Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
XBIT XBiotech Inc
- Stocks
- Healthcare
- NASDAQ: XBIT
Price (delayed)
$2.8
Market cap
$85.37M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.29
Enterprise value
-$70.53M
XBiotech is a fully integrated, global biopharmaceutical company dedicated to pioneering the discovery, development and commercialization of therapeutic antibodies. XBiotech currently is advancing a pipeline of therapies by harnessing naturally
Highlights
XBIT's quick ratio has soared by 152% since the previous quarter and by 142% year-on-year
The debt has shrunk by 100% QoQ and by 100% YoY
XBiotech's net income has decreased by 28% YoY and by 2.3% from the previous quarter
XBiotech's EPS has decreased by 26% YoY and by 2.4% QoQ
Key stats
What are the main financial stats of XBIT
Market
Valuations
Earnings
Shares outstanding
30.49M
Market cap
$85.37M
Enterprise value
-$70.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.49
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$45.17M
Net income
-$39.41M
EBIT
-$38.95M
EBITDA
-$37.19M
Free cash flow
-$31.62M
Per share
Balance sheet
Liquidity
EPS
-$1.29
EPS diluted
-$1.29
Free cash flow per share
-$1.04
Book value per share
$5.73
Revenue per share
$0
TBVPS
$5.97
Total assets
$181.86M
Total liabilities
$7.15M
Debt
$0
Equity
$174.71M
Working capital
$152.28M
Debt to equity
0
Current ratio
29.15
Quick ratio
28.82
Net debt/EBITDA
4.19
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-19.6%
Return on equity
-21.1%
Return on invested capital
-188.3%
Return on capital employed
-22.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
XBIT stock price
How has the XBiotech stock price performed over time
Intraday
-2.44%
1 week
12%
1 month
-5.41%
1 year
-39.26%
YTD
-29.11%
QTD
-13.58%
Financial performance
How have XBiotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$45.17M
Net income
-$39.41M
Gross margin
N/A
Net margin
N/A
XBiotech's net income has decreased by 28% YoY and by 2.3% from the previous quarter
The company's operating income fell by 10% YoY and by 6% QoQ
Price vs fundamentals
How does XBIT's price correlate with its fundamentals
Growth
What is XBiotech's growth rate over time
Valuation
What is XBiotech stock price valuation
P/E
N/A
P/B
0.49
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
XBiotech's EPS has decreased by 26% YoY and by 2.4% QoQ
The P/B is 46% lower than the 5-year quarterly average of 0.9 and 39% lower than the last 4 quarters average of 0.8
The equity has declined by 17% year-on-year and by 4.1% since the previous quarter
Efficiency
How efficient is XBiotech business performance
XBIT's ROIC has shrunk by 133% YoY and by 2.4% QoQ
The return on equity has dropped by 51% year-on-year and by 7% since the previous quarter
XBIT's ROA is down by 46% YoY and by 8% QoQ
Dividends
What is XBIT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did XBiotech financials performed over time
XBIT's quick ratio has soared by 152% since the previous quarter and by 142% year-on-year
The current ratio has soared by 152% from the previous quarter and by 142% YoY
The debt is 100% lower than the equity
The debt to equity has plunged by 100% from the previous quarter and by 100% YoY
The debt has shrunk by 100% QoQ and by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.